‘Immunosequencing’ of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)3motif, recognized by antibody NS4F5, is located towards the non-reducing end

Interfering with UDP-GlcNAc Metabolism and Heparan Sulfate Expression Using a Sugar Analogue Reduces Angiogenesis

(2013) Xander M. van Wijk et al.   ACS Chemical Biology

Highly Sulfated Nonreducing End-derived Heparan Sulfate Domains Bind Fibroblast Growth Factor-2 with High Affinity and Are Enriched in Biologically Active Fractions

(2011) Hicham Naimy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Glycomics Analysis of Mammalian Heparan Sulfates Modified by the Human Extracellular Sulfatase HSulf2

(2011) Gregory O. Staples et al.   PLoS One

A 4-deoxy analogue of N-acetyl-d-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro

(2010) Xander M.R. van Wijk et al.   EXPERIMENTAL CELL RESEARCH

The Heparan Sulfate Motif (GlcNS6S-IdoA2S)3, Common in Heparin, Has a Strict Topography and Is Involved in Cell Behavior and Disease

(2010) Nicole C. Smits et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

ExtendedN-Sulfated Domains Reside at the Nonreducing End of Heparan Sulfate Chains

(2010) Gregory O. Staples et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

6-O-Sulfation of Heparan Sulfate Differentially Regulates Various Fibroblast Growth Factor-dependent Signalings in Culture

(2008) Noriko Sugaya et al.   JOURNAL OF BIOLOGICAL CHEMISTRY